Zacks Investment Research Upgrades Medical Properties Trust (MPW) to “Hold”
Medical Properties Trust (NYSE:MPW) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report issued on Tuesday.
According to Zacks, “Medical Properties Trust, Inc. is a Birmingham, Alabama based self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. These facilities include inpatient rehabilitation hospitals, long-term acute care hospitals, regional and community hospitals, women’s and children’s hospitals, skilled nursing facilities, ambulatory surgery centers, and other single-discipline healthcare facilities, such as heart hospitals, orthopedic hospitals and cancer centers. “
A number of other research firms have also commented on MPW. JPMorgan Chase & Co. raised Medical Properties Trust from an “underweight” rating to a “neutral” rating and set a $14.50 price target on the stock in a research report on Friday, December 15th. ValuEngine raised Medical Properties Trust from a “hold” rating to a “buy” rating in a research report on Thursday, November 9th. SunTrust Banks reaffirmed a “buy” rating and set a $15.00 price target on shares of Medical Properties Trust in a research report on Friday, November 3rd. Robert W. Baird lowered Medical Properties Trust from an “outperform” rating to a “neutral” rating and dropped their price target for the stock from $15.00 to $13.00 in a research report on Friday, January 5th. Finally, Deutsche Bank lowered Medical Properties Trust from a “buy” rating to a “hold” rating and dropped their price target for the stock from $14.00 to $13.50 in a research report on Wednesday, January 10th. Eight investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company. The company has a consensus rating of “Hold” and an average target price of $14.30.
Medical Properties Trust (NYSE:MPW) last released its quarterly earnings results on Thursday, November 2nd. The real estate investment trust reported $0.33 EPS for the quarter, topping the Zacks’ consensus estimate of $0.32 by $0.01. The company had revenue of $176.60 million for the quarter, compared to analyst estimates of $172.57 million. Medical Properties Trust had a return on equity of 7.36% and a net margin of 39.95%. Medical Properties Trust’s revenue was up 39.5% compared to the same quarter last year. During the same quarter last year, the firm posted $0.30 earnings per share. sell-side analysts expect that Medical Properties Trust will post 1.33 EPS for the current year.
Large investors have recently bought and sold shares of the stock. Ffcm LLC bought a new position in shares of Medical Properties Trust during the third quarter worth about $116,000. Janus Henderson Group PLC bought a new position in shares of Medical Properties Trust during the second quarter worth about $136,000. Mcmillion Capital Management Inc. bought a new position in shares of Medical Properties Trust during the third quarter worth about $137,000. Investors Asset Management of Georgia Inc. GA ADV bought a new position in shares of Medical Properties Trust during the fourth quarter worth about $138,000. Finally, Cetera Investment Advisers bought a new position in shares of Medical Properties Trust during the second quarter worth about $141,000. Institutional investors and hedge funds own 81.20% of the company’s stock.
COPYRIGHT VIOLATION WARNING: “Zacks Investment Research Upgrades Medical Properties Trust (MPW) to “Hold”” was first posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this news story on another website, it was illegally copied and reposted in violation of international copyright & trademark laws. The original version of this news story can be read at https://www.thecerbatgem.com/2018/01/18/zacks-investment-research-upgrades-medical-properties-trust-mpw-to-hold.html.
About Medical Properties Trust
Medical Properties Trust, Inc is a real estate investment trust (REIT). The Company focuses on investing in and owning net-leased healthcare facilities across the United States and selectively in foreign jurisdictions. The Company’s segment is its investments in healthcare real estate, including mortgage and other loans, as well as any equity investments in its tenants.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.